CN104056111A - Anti-hepatoma traditional Chinese medicine preparation - Google Patents
Anti-hepatoma traditional Chinese medicine preparation Download PDFInfo
- Publication number
- CN104056111A CN104056111A CN201410326539.6A CN201410326539A CN104056111A CN 104056111 A CN104056111 A CN 104056111A CN 201410326539 A CN201410326539 A CN 201410326539A CN 104056111 A CN104056111 A CN 104056111A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- gram
- medicine preparation
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an anti-hepatoma traditional Chinese medicine preparation which comprises the following crude drugs by weight: 10-20g of coptis chinensis, 10-20g of aloe, 5-10g of sea hare ova, 5-10g of kelp, 5-10g of safflower carthamus, 8-12g of radix isatidis, 8-15g of radix bupleuri, 10-20g of oriental wormwood, 8-12g of fructus forsythiae, 5-10g of periostracum cicada, 10-20g of polygonum cuspidatum, 5-10g of lysimachia christinae hance, 5-10g of peach kernel and 5-10g of tabasheer. By combining the selected drugs, the anti-hepatoma traditional Chinese medicine preparation has the effects of clearing away heat and toxic materials, promoting blood circulation to remove blood stasis, tonifying qi and yin, strengthening the body resistance, removing food retention, diminishing swelling, resisting cancer and the like. Proven by clinical application, the traditional Chinese medicine preparation is capable of effectively reducing the invasiveness of liver cancer, decreasing the postoperative recurrence and migration and improving five-year survival rate and forward recovery rate, and is worthy of clinical popularization and application.
Description
Technical field
The invention belongs to the field of Chinese medicines, specifically a kind of Chinese medicine preparation that can effectively anti-hepatocarcinoma.
Background technology
Hepatocarcinoma refers to the malignant tumor that betides liver, comprises two kinds of primary hepatocarcinoma and secondary liver cancers, and mostly what usually said hepatocarcinoma referred to is primary hepatocarcinoma.Primary hepatocarcinoma is one of modal malignant tumor clinically, can be divided into Hepatocellular carcinoma, intrahepatic cholangiocarcinoma and mixed carcinoma of liver by cell typing.Can be divided into nodular type, massive type and diffuse type by the form of tumor.According to recent statistics, the annual new liver cancer patient approximately 600,000 in the whole world, occupies the 5th of malignant tumor.
Hepatocarcinoma is the third-largest common cancer that mortality rate is only second to gastric cancer, esophageal carcinoma, initial stage symptom is also not obvious, late period main manifestations be that liver pain, appetite decline, vexed swollen, the nausea and vomiting of abdominal part, upper right abdomen dull pain, weak become thin, generate heat edema, skin pruritus etc., if treatment, can cause occurring the life-threatening such as acute abdomen, upper gastrointestinal hemorrhage not in time.
Modern medicine is varied in the method for anti-liver cancer, the curative effects such as doctor trained in Western medicine Radiotherapy chemotherapy, operation certainly, but toxic and side effects is large, main manifestations is bone marrow depression, gastrointestinal reaction, hepatic and renal function damage, cardiac toxicity etc., and medical expense costliness, a lot of patients, owing to being difficult to bear high medical expense, affect the state of an illness adversely.Though Chinese medicine toxic and side effects is little, the most anti-malignant tumor onset of existing medicine is slow, the course for the treatment of is long, seems unable to do what one wishes.
Summary of the invention
The invention solves the defect existing at anti-anticancer aspect at present, a kind of aggressive that can effectively reduce hepatocarcinoma is provided, reduce postoperative recurrence and transfer, improve the Chinese medicine preparation of 5 years survival rates and cure rate at a specified future date.
The technical solution adopted in the present invention is: a kind of Chinese medicine preparation of anti-hepatocarcinoma, it is characterized in that, and described Chinese medicine preparation comprises the Chinese herb of following weight in grams:
Rhizoma Coptidis 10-20 gram, Aloe 10-20 gram, ove Notarchi 5-10 gram, Thallus Laminariae (Thallus Eckloniae) 5-10 gram, Flos Carthami 5-10 gram, Radix Isatidis 8-12 gram, Radix Bupleuri 8-15 gram, Herba Artemisiae Scopariae 10-20 gram, Fructus Forsythiae 8-12 gram, Periostracum Cicadae 5-10 gram, Rhizoma Polygoni Cuspidati 10-20 gram, Herba Lysimachiae 5-10 gram, Semen Persicae 5-10 gram, Concretio Silicea Bambusae 5-10 gram.
As this kind of prioritization scheme:
Described Chinese medicine preparation comprises the Chinese herb of following weight in grams:
10 grams of Rhizoma Coptidis, 10 grams of Aloes, 5 grams of ove Notarchi, 5 grams of Thallus Laminariae (Thallus Eckloniae)s, 5 grams, Flos Carthami, 8 grams of Radix Isatidis, 8 grams of Radix Bupleuri, 10 grams of Herba Artemisiae Scopariaes, 8 grams of Fructus Forsythiaes, 5 grams of Periostracum Cicadaes, 10 grams of Rhizoma Polygoni Cuspidati, 5 grams of Herba Lysimachiaes, 5 grams, Semen Persicae, 5 grams of Concretio Silicea Bambusaes.
As this kind of prioritization scheme:
Described Chinese medicine preparation comprises the Chinese herb of following weight in grams:
15 grams of Rhizoma Coptidis, 15 grams of Aloes, 8 grams of ove Notarchi, 8 grams of Thallus Laminariae (Thallus Eckloniae)s, 8 grams, Flos Carthami, 10 grams of Radix Isatidis, 12 grams of Radix Bupleuri, 15 grams of Herba Artemisiae Scopariaes, 10 grams of Fructus Forsythiaes, 8 grams of Periostracum Cicadaes, 15 grams of Rhizoma Polygoni Cuspidati, 8 grams of Herba Lysimachiaes, 8 grams, Semen Persicae, 8 grams of Concretio Silicea Bambusaes.
As this kind of prioritization scheme:
Described Chinese medicine preparation comprises the Chinese herb of following weight in grams:
20 grams of Rhizoma Coptidis, 20 grams of Aloes, 10 grams of ove Notarchi, 10 grams of Thallus Laminariae (Thallus Eckloniae)s, 10 grams, Flos Carthami, 12 grams of Radix Isatidis, 15 grams of Radix Bupleuri, 20 grams of Herba Artemisiae Scopariaes, 12 grams of Fructus Forsythiaes, 10 grams of Periostracum Cicadaes, 20 grams of Rhizoma Polygoni Cuspidati, 10 grams of Herba Lysimachiaes, 10 grams, Semen Persicae, 10 grams of Concretio Silicea Bambusaes.
The instructions of taking of above-mentioned Chinese medicine preparation is: after the raw material Chinese medicine of above-mentioned weight proportion is mixed, get its medicine juice according to the method for the fried Chinese medicine of tradition, 1 dose of every day, points 2～3 times oral.30 doses was 1 course for the treatment of.Drug withdrawal 2～3 days between the course for the treatment of, then go lower 1 course for the treatment of.
The raw material Chinese medicine of above-mentioned Chinese medicine preparation:
Rhizoma Coptidis, bitter in the mouth, cold in nature; GUIXIN, stomach, liver, large intestine channel.There is heat clearing and damp drying, effect of the removing toxic substances of purging heat.
Aloe, bitter in the mouth, cold in nature; Return liver, stomach, large intestine channel.There is purging liver-heat, effect of relieving constipation by purgation.
Ove Notarchi, sweet in the mouth, salty, cold in nature; Return lung, kidney channel.There is clearing away heat and nourishing YIN, effect of softening the hard mass expectorant.
Thallus Laminariae (Thallus Eckloniae), salty in the mouth, cold in nature; Return liver, kidney channel.There is eliminating phlegm and softening indurated mass, effect of inducing diuresis to remove edema.
Flos Carthami, nature and flavor are pungent, temperature; GUIXIN, Liver Channel.There is promoting blood circulation to restore menstrual flow, effect of eliminating stasis to stop pain.
Radix Isatidis, bitter in the mouth, cold in nature; GUIXIN, stomach, liver, gallbladder meridian.There is heat-clearing and toxic substances removing, effect of removing heat from blood sore-throat relieving.
Radix Bupleuri, bitter in the mouth, pungent, cold nature; GUIXIN, liver, gallbladder, tri-jiao channel.Have to evacuate and bring down a fever, dispersing the stagnated live-QI to relieve the stagnation of QI, effect of elevate a turnable ladder yang-energy.
Herba Artemisiae Scopariae, bitter in the mouth, cold nature; Return spleen, stomach, liver, gallbladder meridian.There is clearing away heat-damp and promoting diuresis, effect of promoting the function of the gallbladder to alleviate jaundice.
Fructus Forsythiae, bitter in the mouth, cold nature; Return lung, the heart, gallbladder meridian.There is heat-clearing and toxic substances removing, effect of eliminating carbuncle eliminating stagnation.
Periostracum Cicadae, sweet in the mouth, salty, cool in nature; Return through lung, Liver Channel.There is dispelling wind-heat, rash sore-throat relieving, effect of removing nebula to improve visual acuity.
Rhizoma Polygoni Cuspidati, bitter in the mouth, cold in nature; Return liver, gallbladder, lung meridian.There is promoting the function of the gallbladder to alleviate jaundice, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, effect of expelling phlegm for arresting cough.
Herba Lysimachiae, sweet in the mouth, salty, cold nature; Return liver, gallbladder, kidney, urinary bladder channel.There is relieving stranguria by diuresis, dampness removing jaundice eliminating, effect of removing toxic substances and promoting subsidence of swelling.
Semen Persicae, nature and flavor are sweet flat, hardship; Return lung, liver, large intestine channel.There is blood circulation promoting and blood stasis dispelling, moisturize effect of laxation.
Concretio Silicea Bambusae, sweet in the mouth, cold in nature; GUIXIN, liver, gallbladder meridian.There is removing heat-phlegm, effect of the arresting convulsion that clears away heart-fire.
The traditional Chinese medical science thinks, mostly liver cancer patient is stagnation of QI due to depression of the liver, for a long time and the raw poison of fire-transformation causes the stasis of blood, and gas, the stasis of blood, poison are mutually due to knot.So-called " seeing the disease of liver, knowing the liver disease will be transmitted into the spleen, in the ban tonifying the spleen ", therefore treatment is worked as with invigorating the spleen and benefiting QI, heat-clearing and toxic substances removing, blood stasis dispelling removing food stagnancy, depressed liver-energy dispersing and QI regulating is principle.In softening the hard mass expectorant Chinese medicine preparation of the present invention, Rhizoma Coptidis, Aloe, Herba Artemisiae Scopariae can heat clearing and damp drying, the removing toxic substances of purging heat; Ove Notarchi, Thallus Laminariae (Thallus Eckloniae), Concretio Silicea Bambusae can softening the hard mass expectorants, clearing away heat and nourishing YIN; Flos Carthami, Rhizoma Polygoni Cuspidati, Semen Persicae can blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, invigorating the spleen and benefiting QI; Radix Isatidis, Fructus Forsythiae can heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation; Radix Bupleuri, Periostracum Cicadae can dispelling wind-heat, dispersing the stagnated live-QI to relieve the stagnation of QI; Herba Lysimachiae can relieving stranguria by diuresis, removing toxic substances and promoting subsidence of swelling; All medicines share the pathogenesis that can hit, row heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, depressed liver-energy dispersing and QI regulating, invigorating the spleen and benefiting QI, effect of detoxicating and fighting cancer.
For further investigating clinical efficacy and the safety of medicine of the present invention, we have selected 92 routine liver cancer patients to carry out clinical experiment, and the age, between 45 years old to 80 years old, is divided into treatment group and matched group at random, every group of 46 examples.Treatment group is taken the embodiment of the present invention 2 Chinese medicine preparation, and 1 dose of fried rear every day, points 2～3 times oral.30 doses was 1 course for the treatment of.Drug withdrawal 2～3 days between the course for the treatment of, then go lower 1 course for the treatment of; Matched group gives Kang ' ai injection 20ml, intravenous drip, or compound light-yellow sophora root 20ml intravenous drip and nutritional support treatment.Two groups of patients are in aspect comparisons such as age, sex, pain, and no significant difference (P > 0.05), has comparability.
Criterion of therapeutical effect (according to WHO solid tumor drugs treatment efficacy assessment standard):
Alleviate completely (CR): tumor disappears and continues more than one month; Clinical symptoms recovery from illness.
Partial rcsponse (PR): two maximum mutual perpendicular diameter products of tumor dwindle more than 50%, and continue more than one month; Clinical symptoms is obviously improved.
Stable (SD): two maximum mutual perpendicular diameter products of tumor dwindle less than 50%, increases and is no more than 25% and lasting more than one month; Clinical symptoms is improved.
Worsen (PD): two maximum mutual perpendicular diameter products increases of tumor exceed 25%; Clinical symptoms is without improvement.
Efficacy result:
That adds up patient's drug administration the results are shown in Table 1.Treat after three courses for the treatment of, because treatment time is shorter, all do not find CR case for two groups, but treatment group PR23 example (50%), SD20 example (43.5%), PD3 example (6.5%); Matched group PR15 example (32.6%), SD18 example (39.1%), PD13 example (32.6%), the total effective rate for the treatment of group is apparently higher than matched group.The clinical earning rate (CBR=CR+PR+SD) for the treatment of group is 93.5%, apparently higher than 71.7% of matched group.Difference has significant (P < 0.005).
Table 1: add up two groups of patient's drug administration result synopsis
Untoward reaction:
Main adverse reaction is digestive tract reaction, treatment group appetite decline and feel sick, vomiting is respectively 2 examples (4.4%) and 3 examples (6.5%), matched group appetite decline and feel sick, vomiting is respectively 3 examples (6.5%) and 2 examples (4.4%), two groups of contrast zero differences, two groups have no hematology's untoward reaction.
Result shows, Chinese medicine preparation of the present invention can improve body's immunity, enhancing body resistance against diseases, improve and improve body substance metabolism, the significantly anti-tumor effect of tumor suppression, to improving the life quality of liver cancer patient, extend life cycle, stablize tumor body and there is significant role.
Detailed description of the invention
Embodiment 1: a kind of Chinese medicine preparation of anti-hepatocarcinoma, choose 10 grams of Rhizoma Coptidis, 10 grams of Aloes, 5 grams of ove Notarchi, 5 grams of Thallus Laminariae (Thallus Eckloniae)s, 5 grams, Flos Carthami, 8 grams of Radix Isatidis, 8 grams of Radix Bupleuri, 10 grams of Herba Artemisiae Scopariaes, 8 grams of Fructus Forsythiaes, 5 grams of Periostracum Cicadaes, 10 grams of Rhizoma Polygoni Cuspidati, 5 grams of Herba Lysimachiaes, 5 grams, Semen Persicae, 5 grams of Concretio Silicea Bambusaes.
Embodiment 2: a kind of Chinese medicine preparation of anti-hepatocarcinoma, choose 15 grams of Rhizoma Coptidis, 15 grams of Aloes, 8 grams of ove Notarchi, 8 grams of Thallus Laminariae (Thallus Eckloniae)s, 8 grams, Flos Carthami, 10 grams of Radix Isatidis, 12 grams of Radix Bupleuri, 15 grams of Herba Artemisiae Scopariaes, 10 grams of Fructus Forsythiaes, 8 grams of Periostracum Cicadaes, 15 grams of Rhizoma Polygoni Cuspidati, 8 grams of Herba Lysimachiaes, 8 grams, Semen Persicae, 8 grams of Concretio Silicea Bambusaes.
Embodiment 3: a kind of Chinese medicine preparation of anti-hepatocarcinoma, choose 20 grams of Rhizoma Coptidis, 20 grams of Aloes, 10 grams of ove Notarchi, 10 grams of Thallus Laminariae (Thallus Eckloniae)s, 10 grams, Flos Carthami, 12 grams of Radix Isatidis, 15 grams of Radix Bupleuri, 20 grams of Herba Artemisiae Scopariaes, 12 grams of Fructus Forsythiaes, 10 grams of Periostracum Cicadaes, 20 grams of Rhizoma Polygoni Cuspidati, 10 grams of Herba Lysimachiaes, 10 grams, Semen Persicae, 10 grams of Concretio Silicea Bambusaes.
Below by concrete case, Chinese medicine preparation curative effect of the present invention is further verified:
Case 1
Hu, man, existing 67 years old.Patient is conscious uncomfortable liver area before 6 years, to examination in hospital, is diagnosed as hepatocarcinoma, after consider oldly, abandoned the treatment such as operative treatment and chemotherapy, start upon somebody's introduction to take Chinese medicine preparation of the present invention, after three courses for the treatment of, physical symptom improves obviously, and patient's complexion is recovered, and appetite is cumulative, pain relief, after hold on and take, the patient so far state of an illness is steady, life is normal.
Case 2
Zhang, man, 50 years old.Patient's in April, 2010 operation of liver cancer recurred after half a year, and original place grows 1.6CM takes advantage of the lump of 1.9CM, after peritoneum, after lymph, shifts, first tire ball 81.44 (normal value is less than 20), take Chinese medicine preparation treatment of the present invention July in then, CT examination after three months, swollen thing obviously dwindles, first tire ball declines. continues to take after 5 months, swollen thing is eliminated, and first tire ball drops to normally, and retroperitoneal lymph node is eliminated, all normals threshold of feeling of patient are now good, recover normal work and life.
Case 3
Lee, man, 43 years old, find primary hepatocarcinoma at the beginning of 2009, do not find the transfer at other positions.The symptoms such as patient presents abdominal distention and pain, weak, becomes thin, and appetite is poor, urine yellow skin, size of tumor is 7.5*10.2cm.Do not do special treatment, directly take Chinese medicine preparation of the present invention by other patients' introduction, patient is by the treatment of first course for the treatment of, and hepatopathy starts to dwindle, and each symptom is improved greatly, has dwindled 6.3*9.4cm when check.After three courses for the treatment of, check tumor narrows down to 4.3*4.9cm.Continue to take after one month, tumor is reduced into 2.3*2.8cm, and b is super to be checked, tumor site has not had blood flow to show.Illustrate that coagulation necrosis has occurred tumor, original position deactivation.Patient continues to be interrupted to take to carry out after treatment, does not recur so far.
Case 4
History, man, 55 years old, patient before 5 years because abdominal distention, stomachache, abdominal circumference increase, the inspection such as weak is diagnosed as liver cirrhosis, splenomegaly, primary hepatocarcinoma.Many January at local hospital conventional therapy, have no and be clearly better.Start after being introduced to take Chinese medicine preparation of the present invention and treat, after a treatment, ascites and jaundice disappear, and patient's states is clearly better, and appetite strengthens.After continuing to take three courses for the treatment of, check, patient's alpha-fetoprotein value obviously declines, and the diseases such as abdominal distention, stomachache, ascites all disappear.Take again two courses for the treatment of and carry out after treatment, the current state of an illness of patient is steady, and indices approaches normal, and wherein alpha-fetoprotein has approached normal value.
Claims (4)
1. a Chinese medicine preparation for anti-hepatocarcinoma, is characterized in that, described Chinese medicine preparation comprises the Chinese herb of following weight in grams:
Rhizoma Coptidis 10-20 gram, Aloe 10-20 gram, ove Notarchi 5-10 gram, Thallus Laminariae (Thallus Eckloniae) 5-10 gram, Flos Carthami 5-10 gram, Radix Isatidis 8-12 gram, Radix Bupleuri 8-15 gram, Herba Artemisiae Scopariae 10-20 gram, Fructus Forsythiae 8-12 gram, Periostracum Cicadae 5-10 gram, Rhizoma Polygoni Cuspidati 10-20 gram, Herba Lysimachiae 5-10 gram, Semen Persicae 5-10 gram, Concretio Silicea Bambusae 5-10 gram.
2. Chinese medicine preparation according to claim 1, is characterized in that, described Chinese medicine preparation comprises the Chinese herb of following weight in grams:
10 grams of Rhizoma Coptidis, 10 grams of Aloes, 5 grams of ove Notarchi, 5 grams of Thallus Laminariae (Thallus Eckloniae)s, 5 grams, Flos Carthami, 8 grams of Radix Isatidis, 8 grams of Radix Bupleuri, 10 grams of Herba Artemisiae Scopariaes, 8 grams of Fructus Forsythiaes, 5 grams of Periostracum Cicadaes, 10 grams of Rhizoma Polygoni Cuspidati, 5 grams of Herba Lysimachiaes, 5 grams, Semen Persicae, 5 grams of Concretio Silicea Bambusaes.
3. Chinese medicine preparation according to claim 1, is characterized in that, described Chinese medicine preparation comprises the Chinese herb of following weight in grams:
15 grams of Rhizoma Coptidis, 15 grams of Aloes, 8 grams of ove Notarchi, 8 grams of Thallus Laminariae (Thallus Eckloniae)s, 8 grams, Flos Carthami, 10 grams of Radix Isatidis, 12 grams of Radix Bupleuri, 15 grams of Herba Artemisiae Scopariaes, 10 grams of Fructus Forsythiaes, 8 grams of Periostracum Cicadaes, 15 grams of Rhizoma Polygoni Cuspidati, 8 grams of Herba Lysimachiaes, 8 grams, Semen Persicae, 8 grams of Concretio Silicea Bambusaes.
4. Chinese medicine preparation according to claim 1, is characterized in that, described Chinese medicine preparation comprises the Chinese herb of following weight in grams:
20 grams of Rhizoma Coptidis, 20 grams of Aloes, 10 grams of ove Notarchi, 10 grams of Thallus Laminariae (Thallus Eckloniae)s, 10 grams, Flos Carthami, 12 grams of Radix Isatidis, 15 grams of Radix Bupleuri, 20 grams of Herba Artemisiae Scopariaes, 12 grams of Fructus Forsythiaes, 10 grams of Periostracum Cicadaes, 20 grams of Rhizoma Polygoni Cuspidati, 10 grams of Herba Lysimachiaes, 10 grams, Semen Persicae, 10 grams of Concretio Silicea Bambusaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410326539.6A CN104056111A (en) | 2014-07-06 | 2014-07-06 | Anti-hepatoma traditional Chinese medicine preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410326539.6A CN104056111A (en) | 2014-07-06 | 2014-07-06 | Anti-hepatoma traditional Chinese medicine preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104056111A true CN104056111A (en) | 2014-09-24 |
Family
ID=51544230
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410326539.6A Pending CN104056111A (en) | 2014-07-06 | 2014-07-06 | Anti-hepatoma traditional Chinese medicine preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104056111A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105664046A (en) * | 2016-03-04 | 2016-06-15 | 李淑华 | Traditional Chinese medicinal preparation for treating liver cancer |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1401340A (en) * | 2001-08-12 | 2003-03-12 | 张淑英 | Health product for liver cancer and preparing process thereof |
| CN102961688A (en) * | 2012-12-06 | 2013-03-13 | 焦克德 | Traditional Chinese medicine decoction capable of reducing alpha fetoprotein and preventing and treating liver cancer |
-
2014
- 2014-07-06 CN CN201410326539.6A patent/CN104056111A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1401340A (en) * | 2001-08-12 | 2003-03-12 | 张淑英 | Health product for liver cancer and preparing process thereof |
| CN102961688A (en) * | 2012-12-06 | 2013-03-13 | 焦克德 | Traditional Chinese medicine decoction capable of reducing alpha fetoprotein and preventing and treating liver cancer |
Non-Patent Citations (2)
| Title |
|---|
| 姜胜攀: "原发性肝癌的中医治法治则与方药刍议", 《中医杂志》 * |
| 张峰，等: "中药为主治疗81 例肝癌临床分析", 《光明中医》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105664046A (en) * | 2016-03-04 | 2016-06-15 | 李淑华 | Traditional Chinese medicinal preparation for treating liver cancer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101884770B (en) | Chinese medicinal preparation for treating urolithiasis and preparation method thereof | |
| CN100490789C (en) | Enteric coated Chinese medicinal capsule for treating cancer and preparation method thereof | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN106390013A (en) | Compound traditional Chinese medicine composition capable of inhibiting colorectal liver metastases as well as preparation method and application thereof | |
| WO2012139314A1 (en) | Chinese herbal medicinal composition for treating cancer | |
| CN101062146A (en) | Chinese traditional medicine for treating gastric cancer and bone cancer | |
| CN102764371B (en) | Traditional Chinese medicine compound prescription for relieving radiotherapy side reactions and preparation method and application thereof | |
| CN107913370A (en) | A kind of medicine and preparation method of therapy of combing traditional Chinese and Western medicine alcoholic liver disease | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN110339276A (en) | Traditional Chinese medicine for treating digestive tract tumor and preparation method thereof | |
| CN104940418A (en) | Pure traditional Chinese medicine pills for treating hepatitis and preparation method thereof | |
| CN104056111A (en) | Anti-hepatoma traditional Chinese medicine preparation | |
| CN103893611A (en) | Drug for treating kidney stone and preparation method of drug | |
| CN106983795A (en) | Chinese medicine composition with antitumor activity and its preparation method and application | |
| CN105168628A (en) | Medicine for treating cellulitis and preparation method thereof | |
| CN101829248A (en) | Traditional Chinese medicine for treating goiter | |
| CN102631449B (en) | Chinese medicinal composition for treating acute pancreatitis | |
| CN104162097A (en) | Traditional Chinese medicine preparation for treating cholelithiasis concurrent with fatty liver | |
| CN1903347A (en) | Medicine composition for treating alimentary canal diseases, prepn. method and application thereof | |
| CN104689239A (en) | Traditional Chinese medicine composition for treating cholelithiasis and preparation method thereof | |
| CN104225016A (en) | Drug composition for treating spleen and stomach deficiency type chronic atrophic gastritis | |
| CN102920977B (en) | Traditional Chinese medicine composition for treating liver cancer | |
| CN103041362A (en) | Drug for treating rheumatism and rheumatoid and preparation method thereof | |
| CN103028028B (en) | Traditional Chinese medicine agent for treating primary hepatic carcinoma | |
| CN106619870A (en) | Composition for treating digestive system neoplasms, and preparation method of composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140924 |